Children ’s National Hospital spinout ReveraGen BioPharma gearing up for muscular dystrophy drug launch

ReveraGen BioPharma just won FDA approval for a treatment it's been developing for 15 years.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 14, 2023 Category: Pharmaceuticals Authors: Sara Gilgore Source Type: news